First day of dealings on AIM for Quantum Pharma
Today, Quantum Pharma Plc started trading Ordinary Shares on AIM (Alternative investment market), a market operated by the London Stock Exchange plc. Quantum Pharma Plc, a growing manufacturer, supplier and service provider to pharmaceutical wholesalers, retail pharmacy, hospitals, pharmaceutical companies, homecare and care home markets, is undertaking the ‘flotation’ as part of plans to expand its offering for pharmacy, primary, secondary care and pharmaceutical companies.
In its ten year history, Quantum Pharma Plc has steadily grown its capabilities and services to the pharmaceutical wholesale and retail pharmacy, hospital, home care and care home markets. Milestones include the upcoming celebration of despatching its 2 millionth specials order, the opening of a state-of-the-art aseptic suite for the production of sterile injectable medicines in 2013, and the 30 per cent increase in users of its Biodose medicines delivery system in the past year.
Andrew Scaife, chief executive officer of Quantum Pharma Plc, said: “Our decision to list the company makes strategic sense as we take Quantum to the next stage of its development. Having established our position as a market leader in the UK niche pharmaceutical market, becoming a Plc will afford us the opportunity to continue expanding to keep ahead of the rapidly changing needs of our customers, their patients and service users and the health service. We’re looking forward to an exciting future for our staff, customers and shareholders.
Posted by: Quantum Administrator on 11th December 2014